Ronald van Ree
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ronald van Ree has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Fatima Ferreira
Department of Biosciences and Medical Biology University of Salzburg Salzburg Austria
1 shared publication Frauke Schocker
Research Center Borstel, Biochemical and Molecular Allergology, Borstel, Germany
1 shared publicationJaap H. Akkerdaas
Academical Medical Center, Department of Experimental Immunology, University of Amsterdam, Amsterdam, The Netherlands
1 shared publicationKlaus Richter
Department of Cell Biology, University of Salzburg, Salzburg, Austria
1 shared publication- Laurian Zuidmeer
Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands
1 shared publication Rob C. Aalberse
Department of Immunopathology, Sanquin, Amsterdem, The Netherlands
1 shared publication
Latest Publications
- 5 January 2006
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 50 (1) , 18-23
Cloning of oleosin, a putative new hazelnut allergen, using a hazelnut cDNA library
The clinical presentation of non‐pollen related allergy to hazelnut can be severe and systemic. So far, only a limited number of non‐pollen related hazelnut allergens have been identified and characterized. The aim of this study was to identify and clone new hazelnut allergens. A lambda ZAP cDNA library of hazelnut was constructed. The library was screened with serum of six hazelnut allergic patients displaying different IgE‐binding patterns on hazelnut immunoblot. Rapid amplification of cDNA ends (RACE) protocols were applied to obtain full‐length clones. Expression experiments were carried out in Eschericchia coli. Expression was monitored by SDS‐PAGE, protein staining and immunoblotting. A hazelnut cDNA library was constructed. IgE screening resulted in the cloning of two isoforms of a novel putative hazelnut allergen. The clones were identified as oleosins, with theoretical molecular masses of 16.7 and 14.7 kDa and pI of 10.5 and 10.0, respectively. The isoforms demonstrated only 37% amino acid sequence identity but contained the typical hydrophobic stretch in the middle of the protein (53% identity) with the characteristic oleosin proline knot region (11/12 amino acids identical). Expression in E. coli of the longer isoform resulted in a clear band on SDS‐PAGE. The expressed protein was recognized on an immunodot blot by IgE from serum that was used for screening the cDNA library. Hazelnut contains multiple isoforms of oleosin. IgE binding of a hazelnut‐allergic patient to a recombinant version suggest that hazelnut oleosin is an allergen, as has been described for peanut and sesame.
- 5 January 2006
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 50 (1) , 18-23
Cloning of oleosin, a putative new hazelnut allergen, using a hazelnut cDNA library
The clinical presentation of non‐pollen related allergy to hazelnut can be severe and systemic. So far, only a limited number of non‐pollen related hazelnut allergens have been identified and characterized. The aim of this study was to identify and clone new hazelnut allergens. A lambda ZAP cDNA library of hazelnut was constructed. The library was screened with serum of six hazelnut allergic patients displaying different IgE‐binding patterns on hazelnut immunoblot. Rapid amplification of cDNA ends (RACE) protocols were applied to obtain full‐length clones. Expression experiments were carried out in Eschericchia coli. Expression was monitored by SDS‐PAGE, protein staining and immunoblotting. A hazelnut cDNA library was constructed. IgE screening resulted in the cloning of two isoforms of a novel putative hazelnut allergen. The clones were identified as oleosins, with theoretical molecular masses of 16.7 and 14.7 kDa and pI of 10.5 and 10.0, respectively. The isoforms demonstrated only 37% amino acid sequence identity but contained the typical hydrophobic stretch in the middle of the protein (53% identity) with the characteristic oleosin proline knot region (11/12 amino acids identical). Expression in E. coli of the longer isoform resulted in a clear band on SDS‐PAGE. The expressed protein was recognized on an immunodot blot by IgE from serum that was used for screening the cDNA library. Hazelnut contains multiple isoforms of oleosin. IgE binding of a hazelnut‐allergic patient to a recombinant version suggest that hazelnut oleosin is an allergen, as has been described for peanut and sesame.
- 1 June 2004
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 4 (3) , 235-240
Clinical importance of cross-reactivity in food allergy
Review of recent developments in the field of cross-reactivity in food allergy and the clinical relevance of these developments. New foods have been added to the list of Bet v 1 and profilin-related food allergies. Clinical relevance of cross-reactions based on recognition of carbohydrate determinants and profilin is limited for the population of pollen-allergic patients as a whole. For selected food allergic patients, however, N-glycans and particularly profilin are potentially of clinical relevance. Lipid transfer proteins have further been established as clinically more severe allergens in several foods. This severity is attributed to their stability to proteolysis and processing. Storage proteins of several nuts and seeds have been identified as important allergens, but cross-reactivity between storage proteins of different foods appears to be limited. Using cross-reactivity as the basis for immunotherapy in food allergy seems promising but needs confirmation by double-blind, placebo-controlled trials. The continued identification and characterization of cross-reactive allergens facilitates the study of factors determining clinical relevance of cross-reactivity and of possible efficacy of immunotherapy in food allergy.
- 1 June 2004
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 4 (3) , 235-240
Clinical importance of cross-reactivity in food allergy
Review of recent developments in the field of cross-reactivity in food allergy and the clinical relevance of these developments. New foods have been added to the list of Bet v 1 and profilin-related food allergies. Clinical relevance of cross-reactions based on recognition of carbohydrate determinants and profilin is limited for the population of pollen-allergic patients as a whole. For selected food allergic patients, however, N-glycans and particularly profilin are potentially of clinical relevance. Lipid transfer proteins have further been established as clinically more severe allergens in several foods. This severity is attributed to their stability to proteolysis and processing. Storage proteins of several nuts and seeds have been identified as important allergens, but cross-reactivity between storage proteins of different foods appears to be limited. Using cross-reactivity as the basis for immunotherapy in food allergy seems promising but needs confirmation by double-blind, placebo-controlled trials. The continued identification and characterization of cross-reactive allergens facilitates the study of factors determining clinical relevance of cross-reactivity and of possible efficacy of immunotherapy in food allergy.